Submitted by Anonymous (not verified) on 25 February 2026 - 14:25
Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation: 05/07/2010, Revision: 23, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation: 05/07/2010, Revision: 23, Status: Authorised